FDA regulation on pharmaceutical cocrystals

FDA has issued a guidance on pharmaceutical cocrystals. This regulation opens the door to fully apply the potential of cocrystals in the pharmaceutical industry.

With a flexible commercial model, we can execute projects through FTE service agreements but also through a variety of different approaches such as fee per success, fee per project or through a shared risk approach.